AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05043337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Maternal voice
Description: The recordings were made in a quiet and separate consultation room. For infants in the maternal voice group, mothers were recorded what they wanted to say to their baby and read an independently published children's book, Xiao Qi's yellow persimmon which describes how mothers with premature babies care for their infants. After reviewing the quality of the recordings, the maternal voice recordings were edited for 13 minutes using a sound organizer. Respiration, heart rate, oxygen saturation, and Neonatal Infant Pain Scale (NIPS) were measured and recorded 3 minutes before, during, 1 minute, 3 minutes, and 10 minutes after the puncture.
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: complete blood count
Description: laboratory test
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: prothrombin time
Description: laboratory test
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: prothrombin time
Description: laboratory test
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: prothrombin concentration
Description: laboratory test
Study NCT05183997 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: prothrombin concentration
Description: laboratory test
Study NCT06334250 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Catheter ablation of atrial fibrillation using Pulsed Field Ablation
Description: Pulsed Field Ablation of atrial fibrillation at the time of left atrial appendage occlusion
Study NCT06334250 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Left atrial appendage occlusion
Description: Left atrial appendage occlusion using the Watchman device
Study NCT06334250 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Left atrial appendage occlusion
Description: Left atrial appendage occlusion using the Watchman device
Study NCT05457023 — intervention group
Intervention type: OTHER
Intervention: Plasma Neurofilament Light (NF-L)
Description: Plasma NF-L is a biomarker of axonal brain injury following sports-related head impacts.
Study NCT05457023 — intervention group
Intervention type: OTHER
Intervention: Omega-3 Index
Description: Omega-3 Index is the omega-3 fatty acid content of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) within the erythrocyte cell membrane. It is expressed as EPA+DHA as a percent of total identified fatty acids.
Study NCT05457023 — intervention group
Intervention type: OTHER
Intervention: HeadCount Questionnaire
Description: HeadCount is a web-based, structured, self-administered questionnaire to assess longer-term heading exposure during competitive play and is administered bi-weekly.
Study NCT05043337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lullaby
Description: The Brahms Lullaby recordings are compiled for 13 minutes. Measuring with the Respiration, heart rate, oxygen saturation, and neonatal infant pain scale (NIPS ) were recorded 3 minutes before, during, 1st, 3rd, and 10th minutes after the heel lance puncture.
Study NCT05043337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Maternal voice combined with lullaby
Description: The recordings were made in a quiet and separate consultation room. For infants in the  Maternal voice combined with lullaby group,  mothers were recorded what they wanted to say to their baby and read an independently published children's book-Xiao Qi's yellow persimmon , and giving mother listening to the Brahms Lullaby at the same time, the maternal voice recordings were edited for 13 minutes using a sound organizer. Measuring with the Respiration, heart rate, oxygen saturation, and neonatal infant pain scale (NIPS ) were recorded 3 minutes before, during, 1st, 3rd, and 10th minutes after the heel lance puncture.
Study NCT05578885 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Bier block
Description: patients in group a (n = 25) received 2% lidocaine3 mg/kg (maximum, 200 mg) for IVRA and 2 mL NaCl 0.9% IV , patients in group b (n = 25) received 2% lidocaine 3 mg/kg (maximum, 200 mg) plus 8 mg dexamethasone for IVRA and 2 mL NaCl 0.9% IV , and those in group c (n = 25) received 2% lidocaine 3 mg/kg (maximum, 200 mg) plus fentanyl IV
Study NCT05578885 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bier block
Description: patients in group a (n = 25) received 2% lidocaine3 mg/kg (maximum, 200 mg) for IVRA and 2 mL NaCl 0.9% IV , patients in group b (n = 25) received 2% lidocaine 3 mg/kg (maximum, 200 mg) plus 8 mg dexamethasone for IVRA and 2 mL NaCl 0.9% IV , and those in group c (n = 25) received 2% lidocaine 3 mg/kg (maximum, 200 mg) plus fentanyl IV
Study NCT05308953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVG-291
Description: NVG-291 is a drug injected under the skin (subcutaneous).
Study NCT05308953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Salt water is being used as a placebo and will be injected under the skin (subcutaneous).
Study NCT06151262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trilaciclib+mFOLFIRINOX
Description: This was a single-arm, exploratory study of the combination of Trilaciclib and mFOLFIRINOX in patients with advanced pancreatic cancer receiving first-line therapy. Observed the incidence of chemotherapy-induced myelosuppression, and imaging was performed every four cycles to assess tumor response.
Study NCT06024304 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Synthes TFNA
Description: Surgical fixation with single-screw device Synthes TFNA; Pelvic fractures will be repaired utilizing single-screw device Synthes TFNA.
Study NCT06024304 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Trigen InterTAN
Description: Surgical fixation with Smith and Nephew Trigen InterTAN cephalomedullary long nail; Pelvic fractures will be repaired utilizing Smith and Nephew Trigen InterTAN.
Study NCT06055296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COMPRENDO Peer Navigation Intervention
Description: Parents randomized to the intervention, COMPRENDO, will receive culture, language, and health literacy-concordant pre-accrual, accrual, and post-accrual activities in person led by a peer navigator for up to 4 weeks. Visit 1 (V1) will provide anticipatory guidance and education on a) general concepts of pediatric cancer research (standard of care, clinical trials, randomization); b) informed consent/assent, research affiliations (e.g., Children's Oncology Group); c) clinical trial types (therapeutic, non-therapeutic); d) voluntariness; and e) frequently asked questions, resources. Navigators will follow a script supported by culture, language and health-literacy concordant handouts and graphic materials, decision aids, and short video-clips. Navigators also provide support with decision-making and answer parents' questions. Three follow-up peer navigator visits (V2, V3, V4) over 4 weeks are tailored to the parents' needs.
Study NCT04825457 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anchoring-tip vs. Conventional
Description: Anchoring-tip: the snare tip was projected from the sheath by 1-2 mm length. Consequently, a small mucosal incision was made at proximal side of lesion. Then the snare was deployed progressively and adjusted around the lesion trying to obtain free margins. At the final step of both conventional and Tip-in EMR, the lesion was resected.~Conventional: After injection of normal saline solution mix, snaring was tried for polyp resection.
Study NCT05183997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verapamil
Description: drug will be add to prolong the effect of regional block
Study NCT06286592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ultra-brief mindfulness intervention video
Description: Details of the specific intervention will be selected in collaboration with the Community Advisory Board.~Then, in a Phase IB trial, we will use a MOST design to assign patients to promising intervention components, combining them and altering exposure time, measuring preliminary effects of possible components of interventions. Details of the specific interventions will be selected in collaboration with the Community Advisory Board.
Study NCT06315608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRG-001
Description: MRG-001 is a clear liquid solution for subcutaneous injection
Study NCT06512389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral solution
Description: 300 mg taken morning and evening
Study NCT06512389 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral solution
Description: 300 mg taken morning and evening
Study NCT05331846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: the smell of breast milk
Description: Smell of breast milk during endotracheal aspiration will reduce pain and stress
Study NCT05085197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1005 injection
Description: Intravenous injection
Study NCT05085197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Intravenous injection
Study NCT03876873 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Head Rotation During Face Mask Ventilation
Description: Participants will receive face mask ventilation in either a neutral head position (practice standard position) or a head rotation position (45 degree angle).
Study NCT03876873 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medline Top Valve Anesthesia Mask
Description: Face mask used per standard of care to provide oxygen to subjects before surgical procedures.
Study NCT04900428 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVI-DROPS
Description: COVI-DROPS is a fully human monoclonal antibody which is a neutralizing antibody to SARS-CoV-2
Study NCT04900428 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Diluent solution
Study NCT04634344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DZD2269
Description: A single dose of DZD2269 starting at 5 mg will be given on Cycle 0 and then followed by a wash-out period. Multiple doses of DZD2269 at the same dose level will be given once daily after the wash-out period.
Study NCT06150586 — intervention group
Intervention type: OTHER
Intervention: Skin Conductance (SC) Measurement
Description: SC will be measured using a specific monitor and three self-adhesive electrodes on one foot of the infant (one plantar and two on the ankles). Peaks per second (the rate of firing in the sympathetic nerves), average amplitude (mean peaks) and area under curve (forcefulness of sympathetic nerve firing) will be automatically analyzed. Corresponding data will be transferred to a separate tablet computer via bluetooth.
Study NCT06150586 — intervention group
Intervention type: OTHER
Intervention: Video Recording
Description: The video recording for later N-PASS assessment will be done by a camera fixed above the incubator / resuscitation unit, not interfering with the LISA procedure. The video will show the full body of the newborn as well as the hands / forearms of the treating clinical team with the awareness and oral consent of the treating team.
Study NCT06116448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high-fidelity simulation
Description: The high-fidelity simulation involved a student and a computer-based mannikin. Prior to the start of the scenario, a pre-briefing session was provided. The scenario was executed with the help of the researcher from the control room. The student's performance during the simulation was recorded with video. Each simulation lasted around 30 minutes. Following the simulation, a debriefing session was held with the student, and feedback was provided. Scales were used to assess the implementation of the practices.
Study NCT01606358 — intervention group
Intervention type: DRUG
Intervention: Carboplatin and / or taxol chemotherapy
Description: Patient with proven epithelial ovarian cancer and receiving carboplatin and / or taxol chemotherapy (usual care).
Study NCT06116448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hybrid simulation
Description: The hybrid simulation involved a student and a standardized patient. The patient wore a wearable breast model and held a model baby. Prior to the start of the scenario, a pre-briefing session was provided. The student's performance during the simulation was recorded with video. Each simulation lasted around 30 minutes. Following the simulation, a debriefing session was held with the student, and feedback was provided. Scales were used to assess the implementation of the practices.
Study NCT06116448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telesimulation
Description: The telesimulation involved a student and a standardized patient. The patient wore a wearable breast model and held a model baby. Students and patients communicated via video conferencing. Prior to the start of the scenario, a pre-briefing session was provided. The student's performance during the simulation was recorded with video. Each simulation lasted around 30 minutes. Following the simulation, a debriefing session was held with the student, and feedback was provided. Scales were used to assess the implementation of the practices.
Study NCT04685941 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Drug-mediated hyperemia
Description: Intracoronary bolus of at least 200 mcg of nitroprussiate or 500 mcg of intracoronary adenosine during 2 minutes. Operators are allowed to combine both drugs.
Study NCT04685941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flow-mediated hyperemia
Description: Intracoronary saline infusion at 20 ml/min via dedicated microcatheter (RayFlow; Hexacath, France) during two minutes.
Study NCT03750825 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIDA Standard Research E-cigarette (SREC)
Description: Smokers will switch to NIDA Standard Research E-cigarette (SREC).
Study NCT06520228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active video games
Description: The experiment was divided into two groups. One experimental group, one control group. The experimental group received an active video game intervention for 12 weeks, 40 minutes twice a week. The control group underwent 12 weeks of traditional physical activity, 40 minutes twice a week.
Study NCT06520228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional sports games
Description: The experiment was divided into two groups. One experimental group, one control group. The experimental group received an active video game intervention for 12 weeks, 40 minutes twice a week. The control group underwent 12 weeks of traditional physical activity, 40 minutes twice a week.
Study NCT05829382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DailyColors™
Description: Capsule containing active ingredient administred daily by the participant during the trial period
Study NCT05829382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule containing placebo administered daily by the participant during the trial period
Study NCT05740059 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Adjusted Transfusion
Description: Patients assigned to the SvO2 group will be transfused if Hb concentration is lower than 9 g/dL and central SvO2 ≤ 65%. Transfusion will be repeated whenever Hb concentration is lower than 9 g/dL and central SvO2 ≤ 65% during surgery and in the ICU (until day 5). Central SvO2 will be measured on a blood sample obtained from the distal lumen of the central venous catheter. Oximetry will be used for measurement with a point-of-care of gas analysis.
Study NCT06295575 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: probiotics containing Bifidobacterium infantis and Lactobacillus
Description: Patients were provided with probiotics containing Bifidobacterium infantis and Lactobacillus. This intervention was started the day after patients' administration and lasted until the day before discharge.
Study NCT06295575 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebos containing lactose
Description: Patients received lactose as placebo.This intervention was started the day after patients' administration and lasted until the day before discharge.
Study NCT05502068 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion
Description: This is a prospective, randomized, double blind, and controlled clinical study to investigate the impact of the high dose vitamin D supplementation on laboratory markers of systemic inflammation such as CRP, ferritin and IL-6 in hospitalized patients with COVID-19. Patients included in the study will be randomized into two groups and receive a placebo (as a control group) or cholecalciferol administered sublingually for 5 day
Study NCT05502068 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion
Description: This is a prospective, randomized, double blind, and controlled clinical study to investigate the impact of the high dose vitamin D supplementation on laboratory markers of systemic inflammation such as CRP, ferritin and IL-6 in hospitalized patients with COVID-19. Patients included in the study will be randomized into two groups and receive a placebo (as a control group) or cholecalciferol administered sublingually for 5 day
Study NCT05618353 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine
Description: 0.6 mg tablets
Study NCT05618353 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study NCT05319691 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yoga
Description: The trial will be 24 weeks long and divided into two distinct parts: an initial 12-week Treatment Phase during which, yoga participants will receive a reproducible standardized weekly yoga intervention delivered virtually with additional resources for home practice, followed by a 12-week Follow-up Phase.
Study NCT04272736 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low calorie protein substitute
Description: The evaluated dietary supplement is a lower calorie amino acid based liquid protein substitute designed for patients with PKU.
Study NCT06404398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OMNICHROMA, Ceram. x spectra
Description: Each patient had two types of veneers.
Study NCT06286592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Forgiveness video
Description: Details of the specific intervention will be selected in collaboration with the Community Advisory Board.~Then, in a Phase IB trial, we will use a MOST design to assign patients to promising intervention components, combining them and altering exposure time, measuring preliminary effects of possible components of interventions. Details of the specific interventions will be selected in collaboration with the Community Advisory Board.
Study NCT06286592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT values video
Description: Details of the specific intervention will be selected in collaboration with the Community Advisory Board.~Then, in a Phase IB trial, we will use a MOST design to assign patients to promising intervention components, combining them and altering exposure time, measuring preliminary effects of possible components of interventions. Details of the specific interventions will be selected in collaboration with the Community Advisory Board.
Study NCT06087848 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
Description: 100 x 106 allogeneic bone marrow (BM)-derived Mesenchymal Stromal Cell (MSC) formulated in sodium chloride supplemented with human serum albumin to be given via slow intravenous infusion in approximately 30 min
Study NCT04847635 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pascal Synthesis 577 sub-threshold laser (Topcon Corporation, Tokyo, Japan)
Description: The subthreshold laser treatment will be performed using subthreshold laser Pascal Synthesis 577 on a customized macular area.
Study NCT04847635 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Pascal Synthesis 577 sham (Topcon Corporation, Tokyo, Japan)
Description: The laser treatment will be performed without any power (only the light beam) using subthreshold laser Pascal Synthesis 577 on a customized macular area.
Study NCT06031246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Selective Lymph Node Dissection
Description: For patients with NSCLC with CTR>0.5 located in the apical segment, the inferior mediastinal lymph node was not need to dissected
Study NCT05601531 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous Tooth Root
Description: An autologous Tooth Root is made from one's own tooth root and covered in an extraction socket where bone graft is placed.
Study NCT05601531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vit.D3
Description: Local administration of Vit.D3, through the effect of Vit.D3 to explore whether it can help to accelerate the healing of tooth extraction cavity and the clinical effectiveness of bone regeneration.
Study NCT05240729 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Infraclavicular brachial plexus block
Description: Using ultrasound in 3different techniques of infraclavicular brachial plexus block
Study NCT05601531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bone graft
Description: Selecting bone materials for alveolar ridge preservation according to treatment needs
Study NCT05491473 — intervention group
Intervention type: DEVICE
Intervention: Closed incisional negative pressure wound therapy (iNPWT) system
Description: The closed incisional negative pressure wound therapy (iNPWT) system (PREVENA Incision Management System, KCI, an Acelity company, San Antonio, Texas, USA)